Abstract/Summary:

Recent studies support a bidirectional interaction between aldosterone and parathyroid hormone (PTH), possibly increasing the individual cardiovascular risk. Primary aldosteronism (PA) and primary hyperparathyroidism can occur simultaneously.  Our aim was to investigate the prevalence of hyperparathyroidism in PA. We performed a case finding of primary hyperparathyroidism in a retrospective series of 503 patients with PA (cohort 1). We analyzed primary and secondary hyperparathyroidism in 141 prospective PA patients who underwent PTH, serum calcium and phosphate measurements at time of diagnosis of PA (cohort 2). Patients with PA frequently have primary or secondary hyperparathyroidism, which is alleviated by correction of PA by surgical or medical means. Patients affected by secondary hyperparathyroidism seem to have a more severe phenotype of PA and have a trend towards more cardiovascular comorbidities.

Authors: Evelyn Asbach, Margareta Bekeran, Anna König, Katharina Lang, Gregor Hanslik, Marcus Treitl, Roland Ladurner, Martin Bidlingmaier, Felix Beuschlein, Marcus Quinkler, Martin Reincke
Keywords: aldosteronism, secondary hyperparathyroidism
DOI Number: 10.1055/a-1027-6472      Publication Year: 2019

To search for other research papers by topic, keyword, author, or year, please go to our Publications page.

©2021 Primary Aldosteronism Foundation — All Rights Reserved

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.

©2021 Primary Aldosteronism Foundation

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.